# How many total human cases of H5 bird flu will CDC report in the United States for 2024 and 2025? (QID: 38991)

- Type: numeric

- URL: https://www.metaculus.com/questions/38991/

- Classifier: health | strategic=False (score=0.00)

### SeenGuard

- enabled=True | lock_status=acquired

- run_filter: before=1 | skipped=0 | after=1

- debug_note=lock acquired

## Research (summary)

CALIBRATION GUIDANCE (auto-generated weekly):
BINARY CALIBRATION
- No resolved binary questions (with pre-resolution forecasts) yet.
- Advice: keep using base rates + small evidence-weighted updates; avoid big swings.

MULTIPLE-CHOICE CALIBRATION (Top-1)
- No resolved MCQ questions (with pre-resolution forecasts) yet.

NUMERIC CALIBRATION (PIT-lite + CRPS)
- No resolved numeric questions (with pre-resolution forecasts) yet.
- When numeric results exist, we’ll check p10/p50/p90 coverage and CRPS.

General takeaway: apply **small** nudges only where gaps are consistent with decent sample sizes (≥10).
— end calibration —

Here is my research plan.

**Step 1: Identify Core Questions**

1.  **What is the baseline trajectory?** What was the rate of case growth from the initial report in 2024 to the latest available data in the provided sources (Jan 2025)?
2.  **What are the primary transmission vectors?** Is the virus still primarily spreading from animals (cattle/poultry) to humans, or is there evidence of sustained human-to-human (H2H) transmission?
3.  **What is the biological risk profile?** What specific evidence exists for the virus "adapting to infect humans better"? Are there known genetic markers to watch for?
4.  **What is the public health and policy response?** How are authorities (CDC, USDA) responding to the outbreak in both humans and animals? Are measures like culling, vaccination (of animals or humans), and PPE mandates for farmworkers being effectively implemented?
5.  **What are the historical analogues?** How does this event compare to previous zoonotic outbreaks like H1N1 (2009), SARS-CoV-1, or other historical H5N1 scares? What can they tell us about plausible outcomes?
6.  **What are the key uncertainties and data limitations?** How comprehensive is surveillance and testing? Could there be a large number of undetected mild or asymptomatic cases?

**Step 2: Propose Search Queries**

1.  **Baseline Trajectory:** (Primarily rely on provided sources, but for external validation): `"CDC H5N1 human cases US 2024 2025"`, `"timeline of H5N1 human cases US dairy cattle outbreak"`.
2.  **Transmission Vectors:** `"H5N1 human to human transmission evidence 2025"`, `"CDC investigation H5N1 case clusters"`, `"H5N1 transmission routes farm workers"`.
3.  **Biological Risk:** `"H5N1 mutations of concern 2025"`, `"genetic analysis H5N1 human cases US"`, `"mammalian adaptation markers H5N1 PB2 E627K"`.
4.  **Public Health Response:** `"USDA H5N1 dairy cattle response 2025"`, `"CDC guidance H5N1 farm workers PPE"`, `"US government H5N1 vaccine stockpile strategy"`, `"Scott Gottlieb H5N1 pandemic preparedness"`.
5.  **Historical Analogues:** `"2009 H1N1 pandemic early case trajectory US"`, `"comparison H5N1 2025 vs H1N1 2009"`, `"lessons from past avian flu outbreaks"`.
6.  **Uncertainties:** `"H5N1 seroprevalence studies US farm workers"`, `"asymptomatic H5N1 human infection rate"`, `"limitations of CDC H5N1 surveillance"`.

**Step 3: Synthesize Key Findings**

*   **Trajectory:** The case count accelerated significantly between Oct 2024 (27 cases) and Jan 2025 (66 cases), an increase of 39 cases in roughly three months. This establishes a new, higher baseline rate of ~13 cases/month among exposed populations.
*   **Transmission:** The provided sources indicate that as of early 2025, most cases are still linked to farm exposure (cattle). There is no confirmed evidence of *sustained* H2H transmission, which remains the critical barrier to a pandemic. However, the "signs of adapting" are the most alarming signal that this barrier could be weakening.
*   **Biology:** The key risk is the virus acquiring mutations that facilitate airborne H2H spread while retaining high virulence. The widespread circulation in mammals (cattle) provides a "mixing vessel" for such adaptations to occur, a scenario long feared by virologists. The first US death also suggests the virus's severity in humans is not diminishing.
*   **Response:** The response appears to be escalating but may have been slow to start. Scott Gottlieb's comments in April 2025 highlight ongoing concerns about public health infrastructure, suggesting the response may not be sufficient to contain a more adapted virus. The effectiveness of measures like PPE use on farms is a key variable.
*   **Analogues:** This situation is distinct from past poultry-only H5N1 outbreaks due to the novel, widespread mammalian reservoir in cattle. It is currently tracking far below the explosive growth of the 2009 H1N1 pandemic but has surpassed the case counts of any prior US avian flu event. It sits in an uneasy middle ground.
*   **Uncertainty:** The official case count is almost certainly an undercount. Testing is likely focused on symptomatic individuals with known exposure. The true number of infections, including mild/asymptomatic ones, is unknown but could be significantly higher.

**Step 4: Draft the Comprehensive Answer**

---

### Reference class & base rates
*   **Sporadic Zoonotic Influenza (US):** Historically, the US sees 0-2 human cases of novel avian influenza per year (e.g., H5N1 in 2022, H7N2 in 2016). The base rate is extremely low, typically <5 cases over a two-year period. The current situation has already dramatically exceeded this baseline.
*   **Contained Zoonotic Outbreaks (Global):** In countries with significant H5N1 in poultry, human case counts have occasionally reached low double digits in a year (e.g., Egypt, Vietnam in the mid-2000s), but rarely exceeded 50 in a single country over two years without evidence of sustained H2H transmission. This class suggests a plausible range of 50-150 cases.
*   **Early-Stage Pandemic Influenza (e.g., 2009 H1N1):** This class represents a low-probability, high-impact scenario. In the first few months of the 2009 H1N1 pandemic, US cases grew exponentially from a handful to thousands, and eventually millions. This reference class implies a final number in the thousands or higher, contingent on the emergence of efficient H2H transmission.

### Recent developments (timeline bullets)
*   **2025-01-14** First US H5N1 death reported; case count rises to 66. — ↑ (large) — Confirms significant virulence in humans and shows a notable acceleration in case detection (~13 cases/month) from the late-2024 baseline.
*   **2025-01-14** Virus shows "signs of adapting to infect humans better." — ↑ (large) — This is the most critical development, suggesting the primary barrier to wider spread (inefficient H2H transmission) may be eroding.
*   **2025-02-01** H5N1 outbreak confirmed on every continent except Australia. — ↑ (small) — Indicates the global animal reservoir is vast and growing, increasing opportunities for mutations and re-introductions into the US.
*   **2025-04-02** Fmr. FDA head Scott Gottlieb expresses concern over public health infrastructure. — ↑ (small) — Suggests that the official response may be lagging behind the biological threat, potentially leading to higher case counts if spread accelerates.
*   **2025-10-29** Review highlights role of travel in spreading resistant pathogens. — neutral/↑ (small) — While not directly about H5N1, it reinforces that if H2H transmission begins, modern travel will spread it rapidly, raising the stakes.

### Mechanisms & drivers (causal levers)
*   **Viral Adaptation for H2H Transmission:** The single most important driver. Any confirmed cluster of H2H cases would fundamentally change the forecast. **Effect size: Large**.
*   **Spread in US Dairy Cattle:** The size of the cattle reservoir directly impacts the number of human exposure opportunities. Further geographic spread or increased prevalence in herds drives risk up. **Effect size: Moderate**.
*   **Surveillance & Testing Intensity:** The number of reported cases is a function of both true infections and testing effort. Expanded testing of farmworkers or wastewater surveillance would likely increase reported cases, even without a change in underlying spread. **Effect size: Moderate**.
*   **Public Health Interventions:** Effective implementation of PPE for farmworkers, culling of infected animals, or potential vaccination of cattle/humans would reduce transmission and lower the final count. **Effect size: Moderate**.
*   **Seasonality:** The upcoming winter of 2025-2026 could increase transmission, as is typical for influenza viruses, providing a seasonal upward pressure on case numbers. **Effect size: Small**.

### Differences vs. the base rate (what’s unusual now)
*   **Novel Mammalian Reservoir:** Unlike past outbreaks centered on poultry, the current spread is sustained in a large, geographically dispersed dairy cattle population. This creates a novel and much larger human-animal interface.
*   **Scale of Exposure:** Millions of cattle and thousands of farmworkers represent a scale of continuous potential exposure far greater than in previous sporadic US avian flu events.
*   **Pre-existing Viral Adaptation:** The virus has already been circulating globally for years, accumulating mutations. The strain spreading in US cattle may be more pre-adapted for mammalian hosts than earlier H5N1 clades.
*   **Heightened Awareness:** Post-COVID-19, public and scientific awareness of pandemic risk is high, potentially leading to faster detection and reporting than in pre-2020 outbreaks, but also potentially more alarm.

### Bayesian update sketch (for the statistician)
*   **Prior:** A reasonable prior based on data up to Oct 2024 (27 cases) would be a Negative Binomial distribution centered around 50-75 total cases, with a long right tail to account for the small but non-zero risk of H2H emergence. Equivalent n: low (~10-20), reflecting high uncertainty.
*   **Evidence mapping:**
    *   ↑ (large): Jump to 66 cases by Jan 2025 and report of viral "adaptation" are strong evidence that the central tendency of the prior was too low and the right tail was not heavy enough.
    *   ↑ (moderate): The first US death confirms the virus's potential for severe outcomes, increasing the urgency and likelihood of more intensive surveillance finding more cases.
    *   ↑ (small): Continued global spread and expert concern about response capabilities suggest that downside risks (successful containment) are less likely.
*   **Net effect:** The posterior distribution should shift significantly upward. The median should move into the 100-200 case range, and the probability mass in the right tail (e.g., >500 cases) should increase substantially.

### Indicators to watch (leading signals; next weeks/months)
*   **UP indicators:**
    *   Any report of a human case with no known animal contact.
    *   A cluster of two or more cases among family members or co-workers.
    *   Identification of key H2H-associated mutations (e.g., PB2 E627K) in human or cattle isolates.
    *   Positive H5N1 detections in urban wastewater systems.
    *   Reports of widespread H5N1 in other mammal populations (e.g., pigs).
*   **DOWN indicators:**
    *   Multiple consecutive weeks with zero new human cases reported by the CDC.
    *   Evidence of successful containment in dairy herds (e.g., declining prevalence).
    *   Genetic sequencing showing viral stability (no new mammalian adaptation markers).
    *   Widespread, mandatory adoption and enforcement of PPE use on farms.

### Caveats & pitfalls
*   **Ascertainment Bias:** The reported number is highly sensitive to testing strategy. A shift to testing asymptomatic workers could dramatically increase the count without a change in the underlying epidemiology.
*   **Definitional Risk:** The resolution depends on CDC reports. A change in CDC's case definition or reporting frequency could alter the final number.

Market snapshot debug:
- Metaculus: no open binary results in response
- Manifold: no open binary results in response

### Sources
- Bird Flu Is Raising Red Flags Among Health Officials (publichealth.jhu.edu) — https://publichealth.jhu.edu/2025/bird-flu-is-raising-red-flags-among-health-officials
- 2020–2025 H5N1 outbreak (en.wikipedia.org) — https://en.wikipedia.org/wiki/2020%E2%80%932025_H5N1_outbreak
- Full interview with former FDA head Scott Gottlieb | POLITICO 2025 Health Care Summit (www.youtube.com) — https://www.youtube.com/watch?v=8C-z-P0E-wQ
- Global trends in travel-related antimicrobial resistance: a systematic review, 2020–2024 (academic.oup.com) — https://academic.oup.com/inthealth/article/16/5/ihaf071/7698305

### Research (debug)

- source=GoogleGrounding | llm=google/gemini-2.5-pro | cached=0 | n_raw=12 | n_kept=4 | cost=$0.030493

- query: None; raising the possibility that the infection could soon gain a foothold among people, with the potential to strike millions.; format; metac_closes_in_period; info; post_id; question_id; United States; Hong Kong; Current Situation Summary; Scott Gottlieb; Clinical Assistant Professor; New York University Grossman School; British Medical Journal; Pasquale Cirillo; Nassim Nicholas Taleb; Disease Control; 2026; 2003; 2016; 2025; 2024; 2005; 1997

### GTMC1 (debug)

- strategic_class=False | strategic_score=0.00 | source=llm

- gtmc1_active=False | qtype=numeric | t_ms=0

- actors_parsed=0

- exceedance_ge_50=None | coalition_rate=None | median=None | dispersion=None

### Ensemble (model outputs)

- OpenRouter-Default: ok=True t_ms=30465 P10=5.000, P50=2024.000, P90=2025.000

- Claude-3.7-Sonnet (OR): ok=True t_ms=27501 P10=5.000, P50=2024.000, P90=2025.000

- Gemini: ok=True t_ms=63269 P10=1.000, P50=5.000, P90=2024.000

- Grok: ok=False t_ms=310



### Per-model (raw + usage/cost)

#### OpenRouter-Default

- ok=True | t_ms=30465 | tokens: prompt=4487, completion=597, total=5084 | cost=$0.017188

```md

To forecast the total number of human cases of H5 bird flu reported by the CDC in the United States for 2024 and 2025, we will follow a structured Bayesian reasoning approach.

### 1. Base Rate (Prior) Selection
- **Base Rate:** Historically, the US has seen very few human cases of novel avian influenza per year, typically less than 5 cases over a two-year period. However, the current situation has already exceeded this baseline with 66 cases reported by January 2025.
- **Reference Distribution:** A Negative Binomial distribution is suitable given the over-dispersion and potential for rare, high-impact events. The prior mean is set around 50-75 cases, with a long right tail to account for the risk of human-to-human (H2H) transmission.

### 2. Comparison to Base Case
- **Similarity:** The current situation is similar to past zoonotic outbreaks in terms of initial animal-to-human transmission.
- **Difference:** The novel mammalian reservoir in cattle and the reported viral adaptation for better human infection are significant deviations, suggesting a higher potential case count.

### 3. Evidence Evaluation (Likelihoods)
- **Increased Case Count:** The rise to 66 cases by January 2025 indicates a higher baseline rate of transmission (~13 cases/month).
- **Viral Adaptation:** Reports of the virus adapting to infect humans better significantly increase the likelihood of higher case counts.
- **Global Spread:** The outbreak's presence on every continent except Australia suggests a vast animal reservoir, increasing mutation opportunities.
- **Public Health Concerns:** Concerns about the adequacy of the public health response suggest a higher likelihood of underreporting and potential spread.

### 4. Bayesian Updating (Posterior Distribution)
- **Update Step:** The prior distribution centered around 50-75 cases is updated with the evidence of 66 cases by January 2025 and viral adaptation. This shifts the posterior mean upward to 100-200 cases, with increased probability mass in the right tail for scenarios exceeding 500 cases.

### 5. Red Team Thinking
- **Overconfidence Check:** Consider the potential for underreporting and the impact of increased surveillance. The true number of cases could be higher.
- **Tail Risks:** The possibility of H2H transmission remains a critical tail risk. If confirmed, the case count could rise exponentially.
- **Alternative Forecast:** A more conservative estimate might focus on containment success, but given the evidence, the higher forecast is justified.

### 6. Final Percentiles
- **Calibrated Percentiles:**
  - P10: 80
  - P20: 100
  - P40: 150
  - P60: 200
  - P80: 300
  - P90: 500

These percentiles reflect the updated understanding of the situation, accounting for the current evidence and potential tail risks.

```

#### Claude-3.7-Sonnet (OR)

- ok=True | t_ms=27501 | tokens: prompt=5116, completion=1367, total=6483 | cost=$0.035853

```md

# Forecasting Human H5 Bird Flu Cases in the US (2024-2025)

## 1. Base Rate (Prior) Selection

For my base rate, I'll use the historical pattern of zoonotic influenza outbreaks in the US, with special attention to the current H5N1 outbreak which is already unusual.

**Historical reference classes:**
- Typical zoonotic avian flu in US: 0-2 cases per year (pre-2024)
- Current outbreak: 27 cases reported by October 2024, accelerating to 66 cases by January 2025
- Contained zoonotic outbreaks globally: 50-150 cases over 2 years without H2H transmission
- Early pandemic scenarios: Thousands+ cases if H2H transmission emerges

Given the data through January 2025 (66 cases), and the current growth rate of ~13 cases/month, a reasonable prior would be:
- Mean/median: ~150-175 cases total for 2024-2025
- Variance: High, with a long right tail to account for potential H2H transmission

## 2. Comparison to Base Case

**Similarities to reference distribution:**
- Still primarily animal-to-human transmission (cattle/poultry exposure)
- No confirmed sustained human-to-human transmission yet
- Primarily affecting people with occupational exposure

**Key differences:**
- Novel mammalian reservoir (dairy cattle) creating unprecedented exposure interface
- First US death reported, confirming significant virulence
- Virus showing "signs of adapting to infect humans better" (January 2025 report)
- Global spread across multiple continents, increasing risk of reintroduction
- Post-COVID heightened surveillance may detect more cases

These differences suggest the distribution should shift upward from historical zoonotic outbreaks, with a heavier right tail.

## 3. Evidence Evaluation (Likelihoods)

**Evidence pushing forecast upward:**
- Acceleration from 27 cases (Oct 2024) to 66 cases (Jan 2025): This represents a ~2.4x increase in just 3 months, establishing a new baseline rate of ~13 cases/month. If this rate continues through Dec 2025, we'd expect ~250 total cases. (Likelihood ratio: ~3:1 favoring higher outcomes)

- "Signs of adapting to infect humans better": This is the most concerning signal, as viral adaptation for human infection is the key barrier to wider spread. Even without sustained H2H transmission, better human adaptation could increase the attack rate among exposed individuals. (Likelihood ratio: ~2:1 favoring higher outcomes)

- First US death reported: Confirms the virus maintains significant virulence in humans, increasing public health concern and likely surveillance intensity. (Likelihood ratio: ~1.5:1 favoring higher outcomes)

**Evidence pushing forecast downward:**
- No confirmed sustained H2H transmission: Despite 66 cases by January 2025, there's no evidence of efficient human spread, which remains the critical barrier to exponential growth. (Likelihood ratio: ~3:1 favoring lower outcomes)

- Heightened awareness post-COVID: Public health authorities are likely more vigilant and may implement stronger containment measures earlier. (Likelihood ratio: ~1.2:1 favoring lower outcomes)

## 4. Bayesian Updating (Posterior Distribution)

Starting with my prior centered around 150-175 cases, I'll update based on the strongest evidence:

**Update 1: Case acceleration**
- Prior: Mean ~162.5 cases
- Evidence: 2.4x increase in 3 months (LR ~3:1 favoring higher outcomes)
- Posterior: Shifts upward to ~200-225 cases

**Update 2: Viral adaptation signals**
- Prior: Mean ~212.5 cases
- Evidence: Signs of better human adaptation (LR ~2:1 favoring higher outcomes)
- Posterior: Shifts upward to ~250-275 cases

**Update 3: No sustained H2H transmission**
- Prior: Mean ~262.5 cases
- Evidence: Absence of H2H spread (LR ~3:1 favoring lower outcomes)
- Posterior: Shifts downward to ~200-225 cases

The posterior distribution has:
- Mean/median: ~210 cases
- Increased variance: The right tail is heavier due to adaptation concerns
- Bimodal shape: Most probability mass around 150-300 cases (continued animal-to-human transmission), with a smaller but significant mass above 500 (if H2H emerges)

## 5. Red Team Thinking

**Potential blind spots:**
- **Underestimating seasonality**: The winter of 2025-2026 could accelerate transmission beyond current rates.
- **Surveillance changes**: CDC might expand testing criteria, artificially increasing case counts without true epidemiological change.
- **Vaccine development**: A human H5 vaccine might be deployed for high-risk workers by late 2025, reducing case counts.
- **Cattle vaccination**: USDA might implement cattle vaccination, reducing the animal reservoir.

**Alternative forecasts:**
- **Lower bound (P10) too high?** If effective containment measures are implemented in dairy farms, or if the virus loses fitness in mammals, we could see case growth stall completely after January 2025.
- **Upper bound (P90) too low?** If even limited H2H transmission emerges, cases could grow exponentially rather than linearly, potentially reaching thousands.

**Adjustments needed:**
- Widen the distribution to account for greater uncertainty
- Increase the weight in the right tail to account for pandemic potential
- Lower the P10 to account for possible successful containment

## 6. Final Percentiles

P10: 90
P20: 130
P40: 180
P60: 240
P80: 350
P90: 550

```

#### Gemini

- ok=True | t_ms=63269 | tokens: prompt=4885, completion=1559, total=11600 | cost=$0.021696

```md

Here is my probabilistic forecast.

### 1. Base Rate (Prior) Selection

The target variable is the total number of human H5 bird flu cases reported by the CDC in the US for 2024 and 2025. A simple base rate of historical sporadic zoonotic flu in the US (0-2 cases/year) is inappropriate, as the 27 cases by October 2024 and 66 cases by January 2025 have already established this as a significant outbreak.

A more appropriate prior can be constructed by extrapolating the most recent trend.
- **Initial Rate (Jan-Oct 2024):** 27 cases in ~9.5 months, or ~2.8 cases/month.
- **Accelerated Rate (Oct 2024 - Jan 2025):** 39 new cases in ~3 months, or ~13 cases/month.

This acceleration suggests the system has changed. My prior will be centered on the extrapolation of this new, higher rate. Forecasting for the remaining ~11.5 months of 2025 at 13 cases/month yields ~150 new cases, for a total of 66 + 150 = 216. I will use a log-normal distribution centered around ~200-250 cases as my prior, with a wide tail to account for the small but non-zero probability of sustained human-to-human (H2H) transmission, which could lead to thousands of cases.

### 2. Comparison to Base Case

The current situation is fundamentally different from past US avian flu events due to one critical factor: a large, widespread mammalian reservoir in dairy cattle.
- **Similarities:** The virus is still primarily zoonotic, with most cases linked to animal exposure. There is no confirmed *sustained* H2H transmission yet.
- **Differences:**
    - **Mammalian Reservoir:** Unlike poultry-focused outbreaks, the cattle reservoir provides a massive, continuous interface for human exposure and viral adaptation.
    - **Accelerating Trend:** The case rate has more than quadrupled in late 2024, indicating a change in transmission dynamics.
    - **Viral Adaptation:** The virus is already circulating widely in mammals, a key step that facilitates adaptation to human hosts.

These differences suggest that my prior, based on simple extrapolation, might be too conservative. The risk is heavily skewed to the upside.

### 3. Evidence Evaluation (Likelihoods)

I will update my prior based on the new information provided in the research report (dated after Jan 14, 2025).

- **Evidence: Virus shows "signs of adapting to infect humans better."** This is the most critical piece of evidence. It makes the primary barrier to a pandemic (inefficient H2H transmission) seem weaker. This is a strong likelihood ratio in favor of much higher numbers, significantly increasing the probability mass in the right tail of the distribution (hundreds or thousands of cases). **Adjustment: Strong upward push.**
- **Evidence: First US H5N1 death reported.** This confirms the virus's severity in humans. Severe outcomes trigger more intensive surveillance, contact tracing, and testing. This will likely increase the number of *reported* cases, even if the underlying infection rate is unchanged. **Adjustment: Moderate upward push.**
- **Evidence: Scott Gottlieb's concern over public health infrastructure.** This expert opinion suggests that containment and response measures may be insufficient if transmission accelerates. This reduces the likelihood of a best-case scenario where the outbreak is quickly controlled. **Adjustment: Small upward push.**
- **Evidence: Global spread to all continents but one.** This increases the global reservoir of the virus, providing more opportunities for dangerous mutations to arise anywhere and potentially spread to the US. **Adjustment: Small upward push.**

All new evidence points toward a higher final count than the initial extrapolation would suggest.

### 4. Bayesian Updating (Posterior Distribution)

- **Prior:** A distribution centered around ~216 cases, with a wide right tail.
- **Likelihoods:** All evidence makes higher outcomes more likely. The "signs of adapting" evidence is particularly powerful.
- **Posterior:** The posterior distribution must shift significantly to the right. The median should move from the low 200s to the mid-to-high 200s. The primary update is to fatten the right tail, increasing the probabilities of outcomes in the high hundreds or low thousands.

My updated mental model considers several scenarios:
1.  **Continued Zoonosis (~50% prob):** The rate continues at 10-20 cases/month. Total cases: 200-350.
2.  **Limited H2H (~30% prob):** Several small, self-limiting H2H clusters occur. Total cases: 350-700.
3.  **Pre-Pandemic (~15% prob):** The virus achieves more efficient (but not perfect) H2H spread, causing stuttering chains of transmission. Total cases: 700-2000.
4.  **Pandemic (~5% prob):** Efficient H2H spread begins before the end of 2025. Total cases: >2000.

The median of my posterior distribution falls between scenarios 1 and 2, while the upper percentiles (P80, P90) are defined by the more severe scenarios.

### 5. Red Team Thinking

A key counterargument is that we have seen zoonotic threats with concerning mutations before that have failed to become pandemics (e.g., H5N1 in the 2000s, MERS). The barrier to efficient airborne transmission in humans is very high. This view would favor a forecast closer to the low end of my range.

However, I rebut this by re-emphasizing the unprecedented nature of the widespread cattle reservoir. This provides a novel "mixing vessel" and a scale of human exposure not seen in prior H5N1 threats. The observed acceleration in cases from 2024 to 2025 is hard data that argues against a simple reversion to a low-case-count baseline.

Another risk is ascertainment bias. A massive increase in testing could inflate the *reported* numbers. My forecast is for reported numbers, so this is a feature, not a bug, of the prediction problem. My central estimate accounts for a continued high level of surveillance.

The main risk to my forecast is underestimating the tail risk. If efficient H2H transmission begins, my P90 of 1200 could be breached very quickly. I believe assigning a 10% probability to an outcome of 1200+ cases appropriately balances the high barrier for a pandemic with the extremely concerning signs of viral adaptation.

### 6. Final Percentiles

My final forecast incorporates the baseline trend, the strong upward pressure from recent evidence of viral adaptation, and the significant tail risk of H2H transmission.

P10: 120
P20: 160
P40: 220
P60: 350
P80: 600
P90: 1200

```

#### Grok

- ok=False | t_ms=310 | tokens: prompt=0, completion=0, total=0 | cost=$0.000000

- error=HTTP 429: Your team 0101076a-72f1-4f25-a038-b346d74bbc8d has either used all available credits or reached its monthly spending limit. To continue making API requests, please purchase more credits or raise your spending limit.

### Aggregation (BMC)

- final_quantiles: P10=-387.58246831173426, P50=1525.724873783619, P90=2837.6530806634705

- bmc_summary={"mean": 1354.9078183626798, "p10": -387.58246831173426, "p50": 1525.724873783619, "p90": 2837.6530806634705}